• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比较帕利哌酮长效制剂与利培酮片治疗精神分裂症患者的血清催乳素浓度。

A comparison of serum prolactin concentrations after administration of paliperidone extended-release and risperidone tablets in patients with schizophrenia.

机构信息

Johnson & Johnson Pharmaceutical Research and Development, Titusville, NJ 08560, USA.

出版信息

J Psychopharmacol. 2010 Jul;24(7):1011-8. doi: 10.1177/0269881109106914. Epub 2009 Oct 13.

DOI:10.1177/0269881109106914
PMID:19825908
Abstract

Increases in serum prolactin concentrations after administration of risperidone have been attributed, by some, to the availability of paliperidone in plasma. This double-blind, randomized, parallel-group study in patients with schizophrenia compared serum prolactin concentrations following the administration of paliperidone extended-release and risperidone immediate-release tablets. At steady state, the doses administered resulted in a similar exposure to paliperidone and the pharmacologically active fraction of risperidone (i.e. risperidone + paliperidone), respectively. Eligible patients were randomized to either paliperidone extended-release 12 mg on days 1-6 or risperidone immediate-release 2 mg on day 1 and 4 mg on days 2-6. Mean serum prolactin concentrations increased on day 1 (C(max): 71.8 ng/ml and 89.7 ng/ml reached at 6.5 hours and 2.6 hours for paliperidone extended-release and risperidone immediate-release, respectively). On day 6, serum prolactin concentration-time profiles were similar for both treatments, with overall higher serum prolactin concentrations than on day 1 (AUC(0-24 h): 1389 and 842 ng h/ml, and 1306 and 741 ng.h/ml on day 6 and day 1 for paliperidone extended-release and risperidone immediate-release, respectively). These results indicate that paliperidone extended-release 12 mg and risperidone immediate-release 4 mg, administered over a period of 6 days, lead to similar elevations in serum prolactin concentrations.

摘要

在一些研究中,利培酮治疗后血清催乳素浓度的增加归因于帕利哌酮在血浆中的可用性。这项双盲、随机、平行组研究比较了精神分裂症患者在服用帕利哌酮长效和利培酮速释片后血清催乳素浓度的变化。在稳态时,所给予的剂量导致帕利哌酮和利培酮的药理活性部分(即利培酮+帕利哌酮)分别具有相似的暴露量。符合条件的患者被随机分为帕利哌酮长效 12 mg 组(第 1-6 天)或利培酮速释 2 mg 组(第 1 天)和 4 mg 组(第 2-6 天)。第 1 天,血清催乳素浓度升高(C(max):帕利哌酮长效和利培酮速释分别为 71.8ng/ml 和 89.7ng/ml,分别在 6.5 小时和 2.6 小时达到)。第 6 天,两种治疗方法的血清催乳素浓度-时间曲线相似,总血清催乳素浓度均高于第 1 天(AUC(0-24 h):帕利哌酮长效和利培酮速释分别为 1389 和 842ng.h/ml,以及 1306 和 741ng.h/ml)。这些结果表明,帕利哌酮长效 12 mg 和利培酮速释 4 mg 在 6 天内给药,导致血清催乳素浓度相似升高。

相似文献

1
A comparison of serum prolactin concentrations after administration of paliperidone extended-release and risperidone tablets in patients with schizophrenia.比较帕利哌酮长效制剂与利培酮片治疗精神分裂症患者的血清催乳素浓度。
J Psychopharmacol. 2010 Jul;24(7):1011-8. doi: 10.1177/0269881109106914. Epub 2009 Oct 13.
2
Paliperidone extended-release tablets for the acute and maintenance treatment of schizophrenia.帕利哌酮缓释片用于精神分裂症的急性和维持治疗。
Clin Ther. 2008 Feb;30(2):231-48. doi: 10.1016/j.clinthera.2008.02.011.
3
Paliperidone ER versus risperidone for neurocognitive function in patients with schizophrenia: a randomized, open-label, controlled trial.帕利哌酮长效注射剂与利培酮治疗精神分裂症患者神经认知功能的随机、开放标签、对照试验。
Int Clin Psychopharmacol. 2012 Sep;27(5):267-74. doi: 10.1097/YIC.0b013e328356acad.
4
A double-blind, placebo-controlled, randomized study evaluating the effect of paliperidone extended-release tablets on sleep architecture in patients with schizophrenia.一项双盲、安慰剂对照、随机研究,评估帕利哌酮缓释片对精神分裂症患者睡眠结构的影响。
Int Clin Psychopharmacol. 2007 Sep;22(5):299-308. doi: 10.1097/YIC.0b013e3281c55f4f.
5
Safety and tolerability of oral paliperidone extended-release tablets in elderly patients with schizophrenia: a double-blind, placebo-controlled study with six-month open-label extension.口服帕利哌酮缓释片在老年精神分裂症患者中的安全性和耐受性:一项为期六个月开放标签扩展的双盲、安慰剂对照研究。
Am J Geriatr Psychiatry. 2008 Jan;16(1):31-43. doi: 10.1097/JGP.0b013e31815a3e7a.
6
Measuring social functioning with the personal and social performance scale in patients with acute symptoms of schizophrenia: interpretation of results of a pooled analysis of three Phase III trials of paliperidone extended-release tablets.用个人和社会表现量表测量处于精神分裂症急性期患者的社会功能:帕利哌酮缓释片三项 III 期临床试验汇总分析结果的解读。
Clin Ther. 2010 Feb;32(2):275-92. doi: 10.1016/j.clinthera.2010.02.003.
7
A comparative study of paliperidone palmitate and risperidone long-acting injectable therapy in schizophrenia.棕榈酸帕利哌酮与利培酮长效注射剂治疗精神分裂症的比较研究。
Prog Neuropsychopharmacol Biol Psychiatry. 2011 Jun 1;35(4):1002-8. doi: 10.1016/j.pnpbp.2011.02.001. Epub 2011 Feb 18.
8
Efficacy and safety of paliperidone extended-release tablets: results of a 6-week, randomized, placebo-controlled study.帕利哌酮缓释片的疗效与安全性:一项为期6周的随机、安慰剂对照研究结果
Biol Psychiatry. 2007 Dec 15;62(12):1363-70. doi: 10.1016/j.biopsych.2007.01.017. Epub 2007 Jun 28.
9
Paliperidone extended-release tablets in schizophrenia patients previously treated with risperidone.帕利哌酮缓释片用于既往接受利培酮治疗的精神分裂症患者。
Int Clin Psychopharmacol. 2008 Jul;23(4):209-15. doi: 10.1097/YIC.0b013e3282fce651.
10
Medication satisfaction in schizophrenia: a blinded-initiation study of paliperidone extended release in patients suboptimally responsive to risperidone.精神分裂症患者的药物满意度:一项针对利培酮反应不佳的患者使用帕利哌酮缓释片的盲法启动研究。
Int Clin Psychopharmacol. 2010 May;25(3):155-64. doi: 10.1097/YIC.0b013e3283372977.

引用本文的文献

1
Association of Prolactin, Oxytocin, and Homocysteine With the Clinical and Cognitive Features of a First Episode of Psychosis Over a 1-Year Follow-Up.催乳素、催产素和同型半胱氨酸与首发精神病患者的临床和认知特征的关联:一项为期 1 年的随访研究
Int J Neuropsychopharmacol. 2023 Nov 24;26(11):796-807. doi: 10.1093/ijnp/pyad051.
2
Long-Acting Injectable Second-Generation Antipsychotics vs Placebo and Their Oral Formulations in Acute Schizophrenia: A Systematic Review and Meta-Analysis of Randomized-Controlled-Trials.长效第二代抗精神病药与安慰剂及其口服制剂治疗急性精神分裂症的随机对照试验的系统评价和荟萃分析。
Schizophr Bull. 2024 Jan 1;50(1):132-144. doi: 10.1093/schbul/sbad089.
3
The Influence of Oxytocin and Prolactin During a First Episode of Psychosis: The Implication of Sex Differences, Clinical Features, and Cognitive Performance.
在首次精神病发作期间,催产素和催乳素的影响:性别差异、临床特征和认知表现的意义。
Int J Neuropsychopharmacol. 2022 Aug 16;25(8):666-677. doi: 10.1093/ijnp/pyac023.
4
Examining Side Effect Variability of Antipsychotic Treatment in Schizophrenia Spectrum Disorders: A Meta-analysis of Variance.精神分裂症谱系障碍中抗精神病药物治疗的副作用变异性研究:方差的荟萃分析。
Schizophr Bull. 2021 Oct 21;47(6):1601-1610. doi: 10.1093/schbul/sbab078.
5
Lumateperone for the Treatment of Schizophrenia.用于治疗精神分裂症的卢马替喷。
Psychopharmacol Bull. 2020 Sep 14;50(4):32-59.
6
Modeling of prolactin response following dopamine D receptor antagonists in rats: can it be translated to clinical dosing?大鼠多巴胺 D 受体拮抗剂后催乳素反应的建模:能否转化为临床给药剂量?
Pharmacol Res Perspect. 2017 Dec;5(6). doi: 10.1002/prp2.364.
7
Pharmacokinetics and Safety of Brexpiprazole Following Multiple-Dose Administration to Japanese Patients With Schizophrenia.多次给药后布雷哌嗪在日本精神分裂症患者中的药代动力学及安全性
J Clin Pharmacol. 2018 Jan;58(1):74-80. doi: 10.1002/jcph.979. Epub 2017 Jul 27.
8
Prolactin Levels After Switching to Paliperidone Palmitate in Patients with Schizophrenia.精神分裂症患者换用棕榈酸帕利哌酮后的催乳素水平
Innov Clin Neurosci. 2016 Jun 1;13(5-6):28-30. eCollection 2016 May-Jun.
9
Dosing and switching of paliperidone ER in patients with schizophrenia: recommendations for clinical practice.帕利哌酮长效注射剂在精神分裂症患者中的剂量调整和转换:临床实践建议。
Ann Gen Psychiatry. 2014 Apr 1;13(1):10. doi: 10.1186/1744-859X-13-10.
10
The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review.新型和新批准的抗精神病药对血清催乳素水平的影响:全面综述。
CNS Drugs. 2014 May;28(5):421-53. doi: 10.1007/s40263-014-0157-3.